Aspire Biopharma Stock Forecast

Sell candidate since Jun 10, 2026 Gain 104.64%

The Aspire Biopharma, Inc. stock price gained 53.73% on the last trading day (Tuesday, 23rd Jun 2026), rising from $0.0201 to $0.0309. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 66.16% from a day low at $0.0263 to a day high of $0.0437. The price has risen in 5 of the last 10 days and is up by 55.28% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 110 thousand more shares were traded than the day before. In total, 111 thousand shares were bought and sold for approximately $3.44 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock.

ASBPW Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, May 29, 2026, and so far it has risen 120.71%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Aspire Biopharma, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aspire Biopharma, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0877. On a fall, the stock will find some support from the short-term average at $0.0217. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Aspire Biopharma, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0241 and $0.0240. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $0.0240 may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0174 between high and low, or 66.16%. For the last week, the stock has had daily average volatility of 92.27%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ASBPW) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Aspire Biopharma, Inc. to open at $0.0336, and during the day (based on 14 day Average True Range), to move between $0 and $0.0797, which gives a possible trading interval of +/-$0.0977 (+/-79 732.41%) up or down from last closing price. If Aspire Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 79 732.41% move between the lowest and the highest trading price during the day. ⚠️ Extreme Volatility Warning: The projected daily trading range exceeds 1000%, indicating exceptionally high volatility. This level of price movement suggests significant market uncertainty and elevated risk. Traders should exercise extreme caution, consider reduced position sizes, and implement strict risk management strategies when trading this security.

With no resistance above and support from accumulated volume @ $0.0241, some $0.0068 (22.01%) from the current price of $0.0309, our system finds the risk reward attractive.

Is Aspire Biopharma, Inc. stock A Buy?

Aspire Biopharma, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.129 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $0.0336 ( 8.85%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk